|
审核状态: Project audit state: |
通过审核 Successful |
|
注册号: Registration number: |
ChiCTR2300077021 |
|
最近更新日期: Date of Last Refreshed on: |
2023-10-26 16:26:36 |
|
注册时间: Date of Registration: |
2023-10-26 00:00:00 |
|
注册号状态: |
预注册 |
|
Registration Status: |
Prospective registration |
|
注册题目: |
超声引导下小针刀椎间内外孔松解治疗巨大型腰椎间盘突出症的临床研究 |
|
Public title: |
Clinical study of ultrasound-guided small needle knife intervertebral foramen release in the treatment of giant lumbar disc herniation |
|
注册题目简写: |
|
|
English Acronym: |
|
|
研究课题的正式科学名称: |
超声引导下小针刀椎间内外孔松解治疗巨大型腰椎间盘突出症的临床研究 |
|
Scientific title: |
Clinical study of ultrasound-guided small needle knife intervertebral foramen release in the treatment of giant lumbar disc herniation |
|
研究课题代号(代码): Study subject ID: |
|
|
在二级注册机构或其它机构的注册号: The registration number of the Partner Registry or other register: |
|
申请注册联系人: |
刘金星 |
研究负责人: |
方伟 |
|
Applicant: |
Jinxing Liu |
Study leader: |
Wei Fang |
|
申请注册联系人电话: Applicant telephone: |
+86 136 9940 7372 |
研究负责人电话:
Study leader's |
+86 159 8331 1710 |
|
申请注册联系人传真 : Applicant Fax: |
研究负责人传真: Study leader's fax: |
||
|
申请注册联系人电子邮件: Applicant E-mail: |
Liujinxingzy@163.com |
研究负责人电子邮件: Study leader's E-mail: |
ms15983311710@163.com |
|
申请单位网址(自愿提供): Applicant website(voluntary supply): |
成都中医药大学附属眉山医院 |
研究负责人网址(自愿提供): Study leader's website(voluntary supply): |
|
|
申请注册联系人通讯地址: |
眉山市东坡区岷东大道北段9号 |
研究负责人通讯地址: |
眉山市东坡区岷东大道北段9号 |
|
Applicant address: |
No. 9, North Section of Mindong Avenue, Dongpo District, Meishan City |
Study leader's address: |
No. 9, North Section of Mindong Avenue, Dongpo District, Meishan City |
|
申请注册联系人邮政编码: Applicant postcode: |
620010 |
研究负责人邮政编码: Study leader's postcode: |
620010 |
|
申请人所在单位: |
成都中医药大学附属眉山医院 |
||
|
Applicant's institution: |
Meishan Hospital of TCM Affiliated to ChengDu University of TCM |
||
|
研究负责人所在单位: |
成都中医药大学附属眉山医院 |
||
|
Affiliation of the Leader: |
Meishan Hospital of TCM Affiliated to ChengDu University of TCM |
||
|
是否获伦理委员会批准: |
是 |
||
|
Approved by ethic committee: |
Yes |
||
|
伦理委员会批件文号: Approved No. of ethic committee: |
2022-055 |
伦理委员会批件附件: Approved file of Ethical Committee: |
查看附件View |
|
批准本研究的伦理委员会名称: |
眉山市中医医院药物器械伦理委员会 |
||
|
Name of the ethic committee: |
Drug Device Ethics Committee of Meishan Hospital of Traditional Chinese Medicine |
||
|
伦理委员会批准日期: Date of approved by ethic committee: |
2022-12-31 00:00:00 | ||
|
伦理委员会联系人: |
任静雯 |
||
|
Contact Name of the ethic committee: |
Jingwen Ren |
||
|
伦理委员会联系地址: |
眉山市东坡区岷东大道北段9号 |
||
|
Contact Address of the ethic committee: |
No. 9, North Section of Mindong Avenue, Dongpo District, Meishan City |
||
|
伦理委员会联系人电话: Contact phone of the ethic committee: |
+86 136 9905 8853 |
伦理委员会联系人邮箱: Contact email of the ethic committee: |
|
|
研究实施负责(组长)单位: |
成都中医药大学附属眉山医院 |
||||||||||||||||||||||
|
Primary sponsor: |
Meishan Hospital of TCM Affiliated to ChengDu University of TCM |
||||||||||||||||||||||
|
研究实施负责(组长)单位地址: |
眉山市东坡区岷东大道北段9号 |
||||||||||||||||||||||
|
Primary sponsor's address: |
No. 9, North Section of Mindong Avenue, Dongpo District, Meishan City |
||||||||||||||||||||||
|
试验主办单位(项目批准或申办者): Secondary sponsor: |
|
||||||||||||||||||||||
|
经费或物资来源: |
四川省中医药管理局 |
||||||||||||||||||||||
|
Source(s) of funding: |
Meishan Hospital of TCM Affiliated to ChengDu University of TCM |
||||||||||||||||||||||
|
研究疾病: |
腰椎间盘突出症 |
||||||||||||||||||||||
|
Target disease: |
Lumbar disc herniation |
||||||||||||||||||||||
|
研究疾病代码: |
|
||||||||||||||||||||||
|
Target disease code: |
|
||||||||||||||||||||||
|
研究类型: |
干预性研究 |
||||||||||||||||||||||
|
Study type: |
Interventional study |
||||||||||||||||||||||
|
研究所处阶段: |
IV期临床试验 | ||||||||||||||||||||||
|
Study phase: |
4 |
||||||||||||||||||||||
|
研究设计: |
随机平行对照 |
||||||||||||||||||||||
|
Study design: |
Parallel |
||||||||||||||||||||||
|
研究目的: |
本研究通过一项随机临床试验,研究超声引导下小针刀椎间内外孔松解术在减轻巨大型腰椎间盘突出症(GLDH)患者疼痛和改善生活质量方面的疗效。提高临床保守治疗GLDH的治疗效果。 |
||||||||||||||||||||||
|
Objectives of Study: |
This study conducted a randomized clinical trial investigating the efficacy of ultrasound-guided small needle knife intervertebral foramen release in reducing pain and improving quality of life in patients with giant lumbar disc herniation (GLDH). Improve the therapeutic effect of clinical conservative treatment of GLDH. |
||||||||||||||||||||||
|
药物成份或治疗方案详述: |
|
||||||||||||||||||||||
|
Description for medicine or protocol of treatment in detail: |
|
||||||||||||||||||||||
|
纳入标准: |
纳入标准 (1)诊断为巨大型腰推间盘突出症,体格检查显示症状定位与腰椎间盘突出阶段相符合; (2)检查未发现马尾神经损伤表现,无进行性加重的神经损伤表现; (3)因本项目需要患者准确描述自身症状,年龄选在成年及以上患者,具有生活自理能力者,年龄范围在18-65岁者(包括18岁和65岁); (4)患者知情同意,了解本项目并自愿加入,同意首选非手术方案进行治疗,同意提供精准的当前现病史及既往病史,愿意按医嘱进行治疗,并按要求完成随访; (5)治疗前1周未接受过其他治疗干预的患者。 |
||||||||||||||||||||||
|
Inclusion criteria |
(1) Diagnosed as giant lumbar disc herniation, physical examination showed that the symptom localization was consistent with the stage of lumbar disc herniation; (2) No cauda equina nerve injury was found in the examination, and there was no progressive aggravation of nerve injury; (3) Because this project requires patients to accurately describe their symptoms, the age is selected as adult and above, those with self-care ability, and those aged 18-65 (including 18-65 years old); (4) The patient has informed consent, understands the program and voluntarily joins, agrees to prefer non-surgical treatment for treatment, agrees to provide accurate current and past medical history, is willing to treat according to medical advice, and completes follow-up as required; (5) Patients who have not received other therapeutic interventions in the 1 week before treatment. |
||||||||||||||||||||||
|
排除标准: |
排除标准 (1)患者存在马尾综合征表现或具有进行性运动神经损伤症状和体征的患者; (2)孕妇、处于哺乳期或准备怀孕的女性; (3)存在严重器质性疾病或精神异常的患者; (4)存在椎间盘脱出、椎间盘退行性不稳定、脊柱结核、肿瘤、骨折或严重骨质疏松症患者; (5)患有严重内科疾病且未予以控制者。具有出血倾向或凝血功能不全者; (6)术区皮肤脓肿、溃烂、水泡或其他皮肤病者; (7)正在接受其他临床试验的患者; |
||||||||||||||||||||||
|
Exclusion criteria: |
Exclusion criteria (1) Patients with cauda equina syndrome manifestations or patients with symptoms and signs of progressive motor nerve injury; (2) Pregnant women, breastfeeding or women planning to become pregnant; (3) Patients with severe organic diseases or mental abnormalities; (4) Patients with intervertebral disc herniation, intervertebral disc degenerative instability, spinal tuberculosis, tumors, fractures or severe osteoporosis; (5) Those who suffer from serious internal medicine diseases and are not controlled. Those with bleeding tendency or coagulation insufficiency; (6) Skin abscess, ulceration, blisters or other skin diseases in the surgical area; (7) Patients undergoing other clinical trials; |
||||||||||||||||||||||
|
研究实施时间: Study execute time: |
从 From 2023-11-01 00:00:00至 To 2024-11-30 00:00:00 |
征募观察对象时间: Recruiting time: |
从 From 2023-11-01 00:00:00 至 To 2024-11-30 00:00:00 |
|
干预措施: Interventions: |
|
|
研究实施地点: Countries of recruitment and research settings: |
|
||||||||||||||||||||||||||||
|
测量指标: Outcomes: |
|
|
采集人体标本:
Collecting sample(s)
|
|
|
征募研究对象情况: Recruiting status: |
正在进行 Recruiting |
年龄范围: Participant age: |
|
||||||
|
性别: |
男女均可 |
Gender: |
Both |
||||||
|
随机方法(请说明由何人用什么方法产生随机序列): |
本实验采用简单随机分组的方法,运用SPSS.25.0软件生成90位随机数字,取中位数45,前45位数字归为针刀组,后45位数字归为对照组。 |
||||||||
|
Randomization Procedure (please state who generates the random number sequence and by what method): |
In this experiment, a simple random group method was adopted, and 90 random numbers were generated by SPSS.25.0 software, the median was 45, the first 45 digits were classified as needle knife group, and the last 45 digits were classified as control group. |
||||||||
|
是否公开试验完成后的统计结果: Calculated Results after the Study Completed public access: |
公开/Public |
|
盲法: |
None |
|
Blinding: |
None |
|
试验完成后的统计结果(上传文件): |
|
|
Calculated Results after
|
|
|
是否共享原始数据: IPD sharing |
否No |
|
共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址): |
无 |
|
The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url): |
None |
|
数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC: |
研究采用CRF表的形式采集数据 |
|
Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture: |
This research collected data in the form of a CRF table |
|
数据与安全监察委员会: Data and Safety Monitoring Committee: |
暂未确定/Not yet |